Lisdexamfetamine Dimesylate Capsules recall: Labeling Error
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Why was Lisdexamfetamine Dimesylate Capsules recalled?
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 25280726A, Exp. Date 03/2027
- Product
- Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
- Recalling firm
- Lannett Company Inc.
- Quantity
- 8544 bottles
- Distribution
- Nationwide within the USA
- Recall date
- September 3, 2025
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)